A detailed history of Continental Advisors LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Continental Advisors LLC holds 361,618 shares of TEVA stock, worth $6.16 Million. This represents 3.14% of its overall portfolio holdings.

Number of Shares
361,618
Previous 403,766 10.44%
Holding current value
$6.16 Million
Previous $6.56 Million 0.69%
% of portfolio
3.14%
Previous 2.88%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $666,359 - $799,126
-42,148 Reduced 10.44%
361,618 $6.52 Million
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $945,720 - $1.29 Million
-74,000 Reduced 15.49%
403,766 $6.56 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $1.74 Million - $2.35 Million
162,900 Added 51.74%
477,766 $6.74 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $211,119 - $276,380
-26,000 Reduced 7.63%
314,866 $3.29 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $542,300 - $775,750
-72,500 Reduced 17.54%
340,866 $3.48 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $313,675 - $412,570
43,566 Added 11.78%
413,366 $3.11 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $530,860 - $721,995
63,500 Added 20.73%
369,800 $3.27 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $1.04 Million - $1.24 Million
131,000 Added 74.73%
306,300 $2.79 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $536,355 - $934,322
-78,186 Reduced 30.84%
175,300 $1.42 Million
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $184,500 - $260,000
-25,000 Reduced 8.98%
253,486 $1.91 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $73,300 - $93,900
-10,000 Reduced 3.47%
278,486 $2.62 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $243,020 - $295,220
29,000 Added 11.18%
288,486 $2.81 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $99,000 - $115,600
10,000 Added 4.01%
259,486 $2.57 Million
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $103,400 - $128,100
-10,000 Reduced 3.85%
249,486 $2.88 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $1.09 Million - $1.39 Million
126,300 Added 94.83%
259,486 $2.5 Million
Q3 2020

Nov 16, 2020

SELL
$8.57 - $12.69 $257,100 - $380,700
-30,000 Reduced 18.38%
133,186 $1.2 Million
Q4 2019

Feb 10, 2020

SELL
$6.53 - $10.72 $52,612 - $86,371
-8,057 Reduced 4.71%
163,186 $1.6 Million
Q1 2019

May 14, 2019

SELL
$15.58 - $20.01 $920,108 - $1.18 Million
-59,057 Reduced 25.64%
171,243 $2.69 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $775,008 - $943,920
-36,800 Reduced 13.78%
230,300 $4.96 Million
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $1.29 Million - $1.89 Million
-76,680 Reduced 22.3%
267,100 $6.5 Million
Q1 2018

May 14, 2018

BUY
$16.68 - $22.07 $850,680 - $1.13 Million
51,000 Added 17.42%
343,780 $5.88 Million
Q4 2017

Feb 13, 2018

BUY
$11.23 - $19.1 $425,392 - $723,508
37,880 Added 14.86%
292,780 $5.55 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $3.93 Million - $8.2 Million
254,900
254,900 $4.49 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Continental Advisors LLC Portfolio

Follow Continental Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continental Advisors LLC with notifications on news.